Apex Healthcare Berhad (KLSE: AHEALTH)

Market Cap	1.74B
Revenue (ttm)	964.28M
Net Income (ttm)	83.14M
Shares Out	720.08M
EPS (ttm)	0.12
PE Ratio	20.83
Forward PE	19.52
Dividend	0.26 (10.74%)
Ex-Dividend Date	Dec 10, 2024

Volume	29,100
Average Volume	56,355
Open	2.400
Previous Close	2.400
Day's Range	2.380 - 2.400
52-Week Range	2.380 - 3.420
Beta	0.36
RSI	42.65
Earnings Date	Feb 25, 2025

About Apex Healthcare Berhad

Apex Healthcare Berhad, an investment holding company, engages in the development, manufacture, marketing, distribution, and wholesaling of pharmaceutical and healthcare products in Malaysia, Singapore, and internationally. It operates through three segments: Manufacturing, Distribution, and Corporate. The company offers a range of products, including cough mixture and antihistamine, anti-infective, anti-diabetic, anti-hypertensive, neuromuscular agent, analgesic, dermatological, and ophthalmological products in the form of tablets, capsules, o...

• Industry: Pharmaceutical Preparations
• Founded: 1962
• Employees: 976
• Stock Exchange: Bursa Malaysia
• Ticker Symbol: AHEALTH

Financial Performance

In 2023, Apex Healthcare Berhad's revenue was 936.17 million, an increase of 6.66% compared to the previous year's 877.74 million. Earnings were 397.99 million, an increase of 294.15%.